OOIR: Observatory of International Research

Papers

(The median citation count of Addiction Science & Clinical Practice is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Smartphone apps for managing alcohol consumption: a literature review	62
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	45
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model	33
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	30
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Netwo	28
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment	27
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled tr	26
Multiple clinical risks for cannabis users during the COVID-19 pandemic	26
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	26
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	25
Racial/ethnic equity in substance use treatment research: the way forward	22
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic	21
Choosing internet-based treatment for problematic alcohol use—why, when and how? Users’ experiences of treatment online	19
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategie	17
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	17
The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review	16
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	15
Integrating traditional practices and social network visualization to prevent substance use: study protocol for a randomized controlled trial among urban Native American emerging adults	15
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	15
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs	15
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	14
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	14
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems	14
What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	14
Substance use disorder bridge clinics: models, evidence, and future directions	14

“It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder	13
What is the prevalence of current alcohol dependence and how is it measured for Indigenous people in Australia, New Zealand, Canada and the United States of America? A systematic review	13
External validation of an opioid misuse machine learning classifier in hospitalized adult patients	13
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients	13
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized contro	12
Study protocol for a group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among young adults experiencing homelessness	12
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis	12
Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?	12
Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities	11
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial	11
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	11
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	11
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	11
Understanding the client characteristics of Aboriginal residential alcohol and other drug rehabilitation services in New South Wales, Australia	10
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care	10
Assessing the readiness of digital data infrastructure for opioid use disorder research	10
What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada	10
One size doesn’t fit all: a thematic analysis of interviews with people who have stopped participating in Narcotics Anonymous in Norway	9
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	9
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown	8
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	8
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	8
Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders	8
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa	8
Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions	8
Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder	8
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study	8
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness tri	8
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	8
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	8
Patient outcomes and experience of a task-shared screening and brief intervention service for problem substance use in South African emergency centres: a mixed methods study	7
Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol	7
Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial	7
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	7
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose	7
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study	7
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	7
Expanding access to medications for opioid use disorder through locally-initiated implementation	6
Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol	6
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	6
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-fe	6
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	6
Information technology and addiction science: promises and challenges	6
Addressing complex pharmacy consultations: methods used to develop a person-centred intervention to highlight alcohol within pharmacist reviews of medications	6
How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians	6
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	6
Electronic cigarettes’ withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study	5
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia	5
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study	5
Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities	5

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone	5
A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial	5
Optimizing internet-delivered cognitive behaviour therapy for alcohol misuse—a randomized factorial trial examining effects of a pre-treatment assessment interview and guidance	5
Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention	5
Chinese- and English-speaking adult current smokers’ perspectives on smoking and culturally and linguistically appropriate cessation: a qualitative analysis	5
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	5
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder	5
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories	5
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	5
Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids	5
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	5
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	4
An online self-directed program combining Community Reinforcement Approach and Family Training and parenting training for concerned significant others sharing a child with a person with problematic al	4
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	4
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	4
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs	4
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics	4
Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis	4
Staff experiences of encountering and treating outpatients with substance use disorder in the psychiatric context: a qualitative study	4
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic	4
Smoking cessation using preference-based tools: a mixed method pilot study of a novel intervention among smokers with low socioeconomic position	4
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	4
A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia	4
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial	4
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	3
Effects of morbidity on smoking cessation: a national smoking cessation program	3
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder	3
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans	3
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians	3
More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments	3
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature	3
Case report: acute care management of severe opioid withdrawal with IV fentanyl	3
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	3
Attitudes and training related to substance use in pediatric emergency departments	3
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging	3
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial	3
“Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic	3
Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study	3
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study	3
A systematic review of substance use screening in outpatient behavioral health settings	3
Using intervention mapping for hookah smoking cessation: a quasi-experimental evaluation	3
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders	3
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	3
Should screening for risk of gambling-related harm be undertaken in health, care and support settings? A systematic review of the international evidence	3
Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities	3
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessne	3
What constitutes “behavioral health”? Perceptions of substance-related problems and their treatment in primary care	3
Integrating patient perspectives in the development of a mobile health intervention to address chronic pain and heavy drinking in primary care: a qualitative study of patients in an urban, safety-net	3
A Health Technician-delivered Brief Intervention linked to AUDIT for reduction of alcohol use in Chilean primary care: a randomized controlled trial	3
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary	3
An Ethnographic study of unhealthy alcohol use in a Danish Emergency Department	3
Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study	3
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis	3
The validation and reliability of a Japanese version of the Problematic Online Gaming Questionnaire (POGQ-J)	3
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	3
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial	3
Patient and provider knowledge of and attitudes toward medical conditions and medication during pregnancy	3
Proceedings of the Addiction Health Services Research (AHSR) 2020: Virtual Conference: Part 2	3